Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Lancet. HIV|August 26, 2024
Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaborationNikos Pantazis, Caroline A Sabin, Sophie Grabar, et al.
Plos One|December 31, 2024
HIV prevention and missed opportunities among people with recently acquired HIV infection: Α protocol for a systematic reviewArgyro Karakosta, Elisa Ruiz-Burga, Shema Tariq, et al.
BMJ Open|May 11, 2023
CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and CanadaElisa Ruiz-Burga, Shema Tariq, Giota Touloumi, et al.
The European Respiratory Journal|February 20, 2025
Incident tuberculosis in people with HIV across Europe from 2012-2022: incidence rates, risk factors, and regional differences in a multicentre cohort studyChristian Kraef, Ashley Roen, Daria Podlekareva, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 14, 2024
Risk of tuberculosis after initiation of antiretroviral therapy among persons with HIV in EuropeIsik S Johansen, Ashley Roen, Christian Kraef, et al.
HIV Medicine|March 2, 2022
Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortiumDathan M Byonanebye, Mark N Polizzotto, Bastian Neesgaard, et al.
AIDS (London, England)|December 11, 2023
Heavy antiretroviral exposure and exhausted/limited antiretroviral options: predictors and clinical outcomesAmanda Mocroft, Annegret Pelchen-Matthews, Jennifer Hoy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2023
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort StudyHortensia Álvarez, Amanda Mocroft, Lene Ryom, et al.
Plos One|December 31, 2020
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortiumBastian Neesgaard, Amanda Mocroft, Robert Zangerle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2020
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency VirusLauren Greenberg, Lene Ryom, Bastian Neesgaard, et al.
Pageof 3